Nexvet Biopharma Ord (NVET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 7,188 | 5,160 | 5,699 | 5,066 | 5,940 |
| Operating Income | -7,188 | -5,160 | -5,699 | -5,066 | -5,940 |
| Other Income | 1,169 | -252 | 604 | 1,097 | 195 |
| Pre-tax Income | -6,019 | -5,412 | -5,095 | -3,969 | -5,745 |
| Net Income Continuous | -6,019 | -5,412 | -5,095 | -3,969 | -5,745 |
| Net Income | $-6,019 | $-5,412 | $-5,095 | $-3,969 | $-5,745 |
| EPS Basic Total Ops | -0.51 | -0.46 | -0.44 | -0.34 | -0.50 |
| EPS Basic Continuous Ops | -0.51 | -0.46 | -0.44 | -0.34 | -0.50 |
| EPS Diluted Total Ops | -0.51 | -0.46 | -0.44 | -0.34 | -0.50 |
| EPS Diluted Continuous Ops | -0.51 | -0.46 | -0.44 | -0.34 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.46 | -0.44 | -0.34 | -0.50 |
| EBITDA(a) | $-6,961 | $-4,959 | $-5,503 | $-4,873 | $-5,777 |